新型插入式伽马探头用于99mTc-PSMA-I&S引导的机器人辅助根治性前列腺切除术中淋巴结检测的可行性
该回顾性分析纳入13例原发性前列腺癌患者,术前给予99mTc-PSMA-I&S后行SPECT/CT,次日行机器人辅助根治性前列腺切除术,术中采用新型机器人插入式伽马探头评估淋巴结站,随后行扩大盆腔淋巴结清扫并以插入式和传统刚性伽马探头行离体对照测量。结果显示该放射引导手术可术中筛查淋巴结转移且安全性可接受,但未能识别2例微小转移(<3 mm)。
要点
- 13例原发性前列腺癌患者中11例高危(中位PSA 11 ng/mL)、2例中危。
- 1例术前SPECT/CT可疑淋巴结经术中插入式探头及最终病理证实。
- 放射引导手术未识别2例微小转移(<3 mm),无相关术后并发症。
核心结论
- 新型插入式伽马探头联合99mTc-PSMA-I&S可在机器人辅助根治性前列腺切除术中对原发前列腺癌行可靠的术中淋巴结转移筛查,安全性可接受。
- 在考虑对有淋巴播散风险的患者省略扩大盆腔淋巴结清扫前,需克服微小转移检测的局限性。
研究设计与样本
- 回顾性分析13例接受放射引导手术的原发性前列腺癌患者数据。
- 术前给予99mTc-PSMA-I&S后行SPECT/CT,次日行机器人辅助根治性前列腺切除术,术中采用新型机器人插入式伽马探头评估淋巴结站,随后行扩大盆腔淋巴结清扫并以插入式和传统刚性伽马探头行离体对照测量。
主要发现
- 11例为高危、2例为中危前列腺癌,高危患者中位PSA值为11 ng/mL。
- 扩大盆腔淋巴结清扫中位清扫淋巴结数为22枚。
- 1例术前SPECT/CT显示可疑淋巴结,经术中机器人插入式探头证实并在最终组织病理学分析中确认。
- 放射引导手术未能于术前和术中识别2例微小转移(<3 mm)。
- 未发生与99mTc-PSMA-I&S放射引导手术或扩大盆腔淋巴结清扫相关的术后并发症。
临床怎么用
- 作者认为,该放射引导手术可在机器人辅助根治性前列腺切除术中对原发前列腺癌行术中淋巴结转移筛查,安全性可接受。
- 作者指出,在考虑对有淋巴播散风险的患者省略扩大盆腔淋巴结清扫前,需克服微小转移检测的局限性。
局限性
- 放射引导手术未能识别2例微小转移(<3 mm)。
- 在考虑对有淋巴播散风险的患者省略扩大盆腔淋巴结清扫前,需克服微小转移检测的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate-specific membrane antigen (PSMA)-targeted radioguided surgery (RGS) has gained increased interest in prostate cancer (PCa). This analysis aims to evaluate the feasibility, safety, and limitations of RGS with a novel drop-in gamma probe in primary PCa. PATIENTS AND METHODS: The data of 13 patients with primary PCa undergoing RGS were analyzed retrospectively. After preoperative administration of 99m Tc-PSMA-I&S, a SPECT/CT was conducted and a robotic radical prostatectomy was performed the following day including intraoperative assessment of the lymph node stations using a novel robotic drop-in gamma probe. This was followed by an extended pelvic lymph node dissection (ePLND) with ex vivo control measurement using the drop-in and a conventional rigid gamma probe. RESULTS: Eleven patients (median PSA value of 11 ng/mL) had high-risk and 2 patients had intermediate-risk PCa. Overall, a median of 22 ePLND lymph nodes were dissected. In 1 patient, preoperative SPECT/CT imaging showed suspicious lymph nodes, which could be confirmed intraoperatively with the robotic drop-in probe and subsequently in the final histopathological analysis. RGS failed to identify 2 patients with micrometastases (<3 mm) preoperatively and intraoperatively. No postoperative complications related to 99m Tc-PSMA-I&S RGS or ePLND occurred. CONCLUSIONS: RGS with the novel drop-in gamma probe and 99m Tc-PSMA-I&S allows for a reliable intraoperative screening for lymph node metastases in robot-assisted radical prostatectomy for primary PCa with an acceptable safety profile. However, limitations in the detection of micrometastases need to be overcome before omitting extended ePLND in patients at risk for lymphatic spread.
引用
- Harke NN, Fuhrmann C, Czerner C, et al. Feasibility of Using a Novel Drop-In Gamma Probe for 99m Tc-PSMA-I&S-Guided Lymph Node Detection During Robot-Assisted Radical Prostatectomy for Primary Prostate Cancer. Clin Nucl Med. 2024. PMID: 38968541. doi:10.1097/RLU.0000000000005385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。